Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization

Circulation: Heart Failure

Volumn 4, Issue 6, 2011, Pages 700-706

  Wong, Yeun Ying ^a   Ruiter, Gerrina ^a   Lubberink, Mark ^a   Raijmakers, Pieter G ^a   Knaapen, Paul ^a   Marcus, J Tim ^a   Boonstra, Anco ^a   Lammertsma, Adriaan A ^a   Westerhof, Nico ^a   Van Der Laarse, Willem J ^a   Vonk Noordegraaf, Anton ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Idiopathic pulmonary arterial hypertension; Oxygen supply and consumption; Positron emission tomography; Right ventricular failure; Right ventricular mechanical efficiency

Indexed keywords

OXYGEN; GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HEART CATHETERIZATION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE PERFORMANCE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PULMONARY ARTERY HYPERTENSION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; CLASSIFICATION; COMORBIDITY; COMPARATIVE STUDY; HEART MUSCLE; HEART OUTPUT; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; UNITED STATES;

ADULT; CARDIAC OUTPUT; COMORBIDITY; FEMALE; GLUCOSE; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; NEW YORK; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84855576252     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.962381     Document Type: Article

References (40)

1. Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol. 2001;38:1137-1142. (Pubitemid 32912723)
2. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001;104: 2407-2411. (Pubitemid 33108372)
3. Murray AJ, Cole MA, Lygate CA, Carr CA, Stuckey DJ, Little SE, Neubauer S, Clarke K. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol. 2008;44:694-700.
4. Laine H, Katoh C, Luotolahti M, Yki-Jarvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation. 1999;100:2425-2430.
5. Agostini D, Iida H, Takahashi A, Tamura Y, Henry Amar M, Ono Y. Regional myocardial metabolic rate of oxygen measured by O2-15 inhalation and positron emission tomography in patients with cardiomyopathy. Clin Nucl Med. 2001;26:41-49. (Pubitemid 32003182)
6. Nichols AB, Pearson MH, Sciacca RR, Cannon PJ. Left ventricular mechanical efficiency in coronary artery disease. J Am Coll Cardiol. 1986;7:270-279. (Pubitemid 16164406)
7. Shinke T, Takaoka H, Takeuchi M, Hata K, Kawai H, Okubo H, Kijima Y, Murata T, Yokoyama M. Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to betaadrenergic stimulation in patients with idiopathic dilated cardiomyopathy. Circulation. 2000;101:1925-1930. (Pubitemid 30225273)
8. Tuunanen H, Engblom E, Naum A, Nagren K, Hesse B, Airaksinen KEJ, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation. 2006;114:2130-2137. (Pubitemid 44747893)
9. Kim IS, Izawa H, Sobue T, Ishihara H, Somura F, Nishizawa T, Nagata K, Iwase M, Yokota M. Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm. J Am Coll Cardiol. 2002;39:1264-1268. (Pubitemid 34297864)
10. Knaapen P, Germans T, Knuuti J, Paulus WJ, Dijkmans PA, Allaart CP, Lammertsma AA, Visser FC. Myocardial energetics and efficiency: current status of the noninvasive approach. Circulation. 2007;115: 918-927. (Pubitemid 46294732)
11. Lubberink M, Wong YY, Raijmakers PGHM, Schuit RC, Luurtsema G, Boellaard R, Knaapen P, Vonk-Noordegraaf A, Lammertsma AA. Myocardial oxygen extraction fraction measured using bolus inhalation of 15O-oxygen gas and dynamic PET. J Nucl Med. 2011;52:60-66.
12. Knaapen P, van Campen LMC, de Cock CC, Gotte MJW, Visser CA, Lammertsma AA, Visser FC. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation. 2004;110: 646-651. (Pubitemid 39056261)
13. Luurtsema G, Boellaard R, Greuter HNJM, Rijbroek A, Takkenkamp K, de Geest FGM, Buijs FL, Harry Hendrikse N, Franssen EJF, Van Lingen A, Lammertsma AA. Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting. J Clin Pharm Ther. 2010;35:63-69.
14. Iida H, Rhodes CG, Araujo LI, Yamamoto Y, de Silva R, Maseri A, Jones T. Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography: theory, error analysis, and application in humans. Circulation. 1996;94: 792-807. (Pubitemid 26289238)
15. Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med. 1998;25:751-759. (Pubitemid 28377039)
16. Iida H, Rhodes CG, de Silva R, Yamamoto Y, Araujo LI, Maseri A, Jones T. Myocardial tissue fraction: correction for partial volume effects and measure of tissue viability. J Nucl Med. 1991;32:2169-2175.
17. Mauritz GJ, Marcus JT, Westerhof N, Postmus PE, Vonk-Noordegraaf A. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart. 2011;97:473-478.
18. Mauritz GJ, Marcus JT, Boonstra A, Postmus PE, Westerhof N, Vonk Noordegraaf A. Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson. 2008;10:51.
19. Saouti N, Westerhof N, Helderman F, Marcus JT, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med. 2010;182:1315-1320.
20. Kusachi S, Nishiyama O, Yasuhara K, Saito D, Haraoka S, Nagashima H. Right and left ventricular oxygen metabolism in open-chest dogs. Am J Physiol. 1982;243:H761-H766. (Pubitemid 13250943)
21. Hart BJ, Bian X, Gwirtz PA, Setty S, Downey HF. Right ventricular oxygen supply/demand balance in exercising dogs. Am J Physiol Heart Circ Physiol. 2001;281:H823-H830.
22. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med. 1994;121:409-415.
23. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002;40:780-788. (Pubitemid 34925627)
24. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986;55:449-458. (Pubitemid 16122489)
25. Marcus JT, Gan CT, Zwanenburg JJM, Boonstra A, Allaart CP, Gotte MJW, Vonk Noordegraaf A. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol. 2008;51:750-757. (Pubitemid 351221219)
26. Gan CT-J, Holverda S, Marcus JT, Paulus WJ, Marques KM, Bronzwaer JGF, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest. 2007;132:11-17. (Pubitemid 47068197)
27. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med. 2007;175:846-850. (Pubitemid 46631797)
28. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26: 1993-1999. (Pubitemid 41435724)
29. Handoko ML, De Man FS, Happe CM, Schalij I, Musters RJP, Westerhof N, Postmus PE, Paulus WJ, Van Der Laarse WJ, Vonk Noordegraaf A. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation. 2009;120:42-49.
30. Mouchaers KTB, Schalij MJ, Versteilen AMG, Hadi AM, Van Nieuw Amerongen GP, Van Hinsbergh VWM, Postmus PE, Van Der Laarse WJ, Vonk Noordegraaf A. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2009;297:H200-H207.
31. Wong YY, Handoko ML, Mouchaers KTB, De Man FS, Vonk Noordegraaf A, Van Der Laarse WJ. Reduced mechanical efficiency of rat papillary muscle related to degree of hypertrophy of cardiomyocytes. Am J Physiol Heart Circ Physiol. 2010;298:H1190-H1197.
32. Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, Shirato K. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005;45:1849-1855. (Pubitemid 40779867)
33. Nagaya N, Goto Y, Satoh T, Uematsu M, Hamada S, Kuribayashi S, Okano Y, Kyotani S, Shimotsu Y, Fukuchi K, Nakanishi N, Takamiya M, Ishida Y. Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. J Nucl Med. 1998;39:1676-1680. (Pubitemid 28473511)
34. Piao L, Fang YH, Cadete VJJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, Lopaschuk GD, Archer SL. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med. 2010;88:47-60.
35. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115:500-508. (Pubitemid 40322219)
36. de Jong JW, Schoemaker RG, de Jonge R, Bernocchi P, Keijzer E, Harrison R, Sharma HS, Ceconi C. Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol. 2000; 32:2083-2089.
37. Farahmand F, Hill MF, Singal PK. Antioxidant and oxidative stress changes in experimental cor pulmonale. Mol Cell Biochem. 2004;260: 21-29. (Pubitemid 39127568)
38. Nagendran J, Gurtu V, Fu DZ, Dyck JRB, Haromy A, Ross DB, Rebeyka IM, Michelakis ED. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg. 2008;136:168-178.
39. Shinke T, Shite J, Takaoka H, Hata K, Inoue N, Yoshikawa R, Matsumoto H, Masai H, Watanabe S, Ozawa T, Otake H, Matsumoto D, Hirata KI, Yokoyama M. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J. 2007;154: 645-648.
40. Redout EM, van der Toorn A, Zuidwijk MJ, van de Kolk CWA, van Echteld CJA, Musters RJP, van Hardeveld C, Paulus WJ, Simonides WS. Antioxidant treatment attenuates pulmonary arterial hypertensioninduced heart failure. Am J Physiol Heart Circ Physiol. 2010;298:H1038-H1047.